As the month draws to a close, the biopharma sector appears to be holding its own during a period of political instability in Washington that threatens to delay the implementation of long-awaited tax and health care reforms. Read More
HONG KONG – Cancer in China is on the rise, and so is the demand for innovative cancer treatments. Local and multinational drugmakers are racing to tap into the growing need for new and effective treatments. Read More
In the quest to understand what determines whether checkpoint blockade will work for a given patient, new research points to epigenetic factors. Read More
TEL AVIV, Israel – Israel has plenty of innovators and researchers and is pumping out new innovative ideas and research at record speed, but a lack of infrastructure may be holding the industry back and preventing the emergence of companies of global stature. Read More
TEL AVIV, Israel – A presentation in early June to the American Society of Clinical Oncology (ASCO) will mark yet another small step in Israeli firm Compugen Ltd.'s ongoing effort to transform itself from a computational drug target discovery company into a preclinical or even clinical-stage drug company. Read More
Trillium Therapeutics Inc., of Toronto, priced an underwritten public offering of 2.75 million shares and 3.25 million series II nonvoting convertible first preferred shares. Read More
Hookipa Biotech AG, of Vienna, highlighted the publication in Nature Communications of research data in a transgenic mouse model showing how its replicating viral vector platform TheraT delivers innate immune activation, including key alarmin signals. Read More
So wrote the Australian University of Melbourne's Samuel Berkovic, telling it like it is with respect to the medical use of cannabinoids in epileptic patients. Despite spectacular anecdotes in the lay press, peer-reviewed data supporting the practice has been sorely lacking. Read More
